TRAIL-R1-targeted chimeric
antigen receptor T cells exhibit dual antitumor effects
Yaru Nai a,
1, Li Dua,
1, Meiying Shenb, Tingting Lia, Jingjing Huanga, Xiaojian Hana, Feiyang Luoa, Da Pangb, Aishun Jina,
*
a Chongqing Key
Laboratory of Basic and Translational Research of Tumor Immunology,
Chongqing Medical University, Chongqing 400016, China
b Department of
Breast Surgery, Harbin Medical University Cancer Hospital, Harbin
150081, China
* Corresponding authors at: Chongqing
Key Laboratory of Basic and Translational Research of Tumor Immunology,
Chongqing Medical University, No.1 Medical College Road, Yuzhong
District, Chongqing 400016, People’s Republic of China.
E-mail addresses :
aishunjin@cqmu.edu.cn.
1 These authors
contributed equally to this research.